Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Prepublished online as a Blood First Edition Paper on November 27, 2002; DOI 10.1182/blood-2002-09-2898.

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2002-09-2898v1
101/7/2591    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Papadaki, H. A
Right arrow Articles by Eliopoulos, G. D
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Papadaki, H. A
Right arrow Articles by Eliopoulos, G. D
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted September 23, 2002
Accepted November 18, 2002

Impaired granulocytopoiesis in patients with chronic idiopathic neutropenia is associated with increased apoptosis of bone marrow myeloid progenitor cells

Helen A Papadaki*, Aristides G Eliopoulos, Theodoros Kosteas, Claudia Gemetzi, Athina Damianaki, Helen Koutala, Juergen Bux, and George D Eliopoulos

Hematology, University of Crete School of Medicine, Heraklion, Crete, Greece
Cancer Research UK Institute for Cancer Studies of the University of Birmingham Medical School, Birmingham, United Kingdom
Institute of Molecular Biology and Biotechnology, Heraklion, Crete, Greece
Institute of Clinical Immunology and Transfusion Medicine of the Justus-Liebig University, Giessen, Germany

* Corresponding author; email: epapadak{at}med.uoc.gr.

To probe the pathophysiologic mechanism(s) underlying neutropenia in patients with chronic idiopathic neutropenia (CIN) with hypoplastic and left shifted granulocytic series in the bone marrow (BM), we have studied granulocytopoiesis in 32 CIN adults by evaluating the number and survival characteristics of cells in several stages of granulocyte differentiation using flow-cytometry and BM culture assays. We found that CIN patients displayed low percentage of CD34+/CD33+ cells, defective granulocyte colony-forming unit (CFU-G) growth potential of BM mononuclear or purified CD34+ cells and low CFU-G recovery in long-term BM cultures (LTBMC), compared to controls (n=46). Low percentage of CD34+/CD33+ cells in patients was associated with accelerated apoptosis and Fas over-expression within this cell compartment, compared to controls. No significant difference was documented in the percentage of apoptotic cells or the Fas+ cells within the fractionated CD34+/CD33-, CD34-/CD33+, CD34-/CD33-/CD15+ BM subpopulations or the peripheral blood neutrophils, suggesting that the underlying cellular defect in CIN probably concerns the committed granulocyte progenitors. LTBMC stromal layers from patients produced abnormally high amounts of tumor necrosis factor-{alpha} and cytokine levels in culture supernatants inversely correlated with the number of myeloid progenitor cells and positively with the proportion of apoptotic CD34+ cells. Patient LTBMC stromal layers displayed pathologic interferon-{gamma} and Fas-Ligand mRNA expression and failed to support normal myelopoiesis. These data suggest that impaired granulocytopoiesis in CIN is probably due to overproduction of inflammatory cytokines by immune cells within the BM microenvironment that may exert an inhibitory effect on myelopoiesis by inducing Fas-mediated apoptosis in the granulocyte progenitors.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
A. Boula, M. Voulgarelis, S. Giannouli, G. Katrinakis, M. Psyllaki, C. Pontikoglou, F. Markidou, G. D. Eliopoulos, and H. A. Papadaki
Effect of cA2 Anti-Tumor Necrosis Factor-{alpha} Antibody Therapy on Hematopoiesis of Patients with Myelodysplastic Syndromes.
Clin. Cancer Res., May 15, 2006; 12(10): 3099 - 3108.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. C. Davies, J. Mason, M. J. O. Wakelam, L. S. Young, and A. G. Eliopoulos
Inhibition of Phosphatidylinositol 3-Kinase- and ERK MAPK-regulated Protein Synthesis Reveals the Pro-apoptotic Properties of CD40 Ligation in Carcinoma Cells
J. Biol. Chem., January 9, 2004; 279(2): 1010 - 1019.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
N. Berliner, M. Horwitz, and T. P. Loughran Jr.
Congenital and Acquired Neutropenia
Hematology, January 1, 2004; 2004(1): 63 - 79.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. A. Papadaki, M. Horwitz, S. A. Coulocheri, R. A. Person, K. F. Benson, and G. D. Eliopoulos
Low levels of serum elastase are not associated with mutations in ELA-2 elastase encoding gene in chronic idiopathic neutropenia
Blood, April 1, 2003; 101(7): 2898 - 2898.
[Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2002 by American Society of Hematology         Online ISSN: 1528-0020